|
Thu, 04/24/2025 - 18:09 |
CIRM awards $8 million to advance vision loss gene therapy to clinical trials |
CIRM |
|
Thu, 06/20/2024 - 13:49 |
Astellas Announces Sponsored Research Agreement with UMass Chan Medical School |
Astellas |
|
Wed, 06/12/2024 - 23:09 |
Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications |
Cellectis |
|
Thu, 12/15/2022 - 21:24 |
Ferring Receives Approval from U.S. FDA for Adstiladrin for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer |
Ferring Pharmac... |
|
Mon, 11/07/2022 - 08:30 |
Announcement of Termination of Co-Development and Exclusive MarketingAgreements with Takara Bio for NY-ESO-1siTCR gene therapy candidate |
Otsuka |
|
Tue, 10/11/2022 - 23:01 |
FDA Accepts BioMarin's Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Adults with Severe Hemophilia A |
BioMarin |
|
Mon, 10/10/2022 - 07:25 |
Amwins Group Benefits Launches Gene Therapy Solutions Program Exclusively Available Through Stealth Partner Group |
AmWINS |
|
Tue, 06/28/2022 - 23:14 |
'We have an enormous opportunity here': Philadelphia cell and gene therapy jobs increases 127% since 2019 |
University City... |
|
Wed, 06/22/2022 - 07:31 |
Mana.bio integrates CAS chemical substance data into its novel drug delivery AI platform |
Chemical Abstra... |
|
Tue, 05/24/2022 - 08:44 |
FDA Accepts CSL Behrings Biologics License Application for Etranacogene Dezaparvovec for Priority Review |
CSL Behring |
|
Mon, 05/16/2022 - 11:41 |
Spirovant Launches State-of-the-Art Laboratory and Headquarters |
University City... |
|
Tue, 04/12/2022 - 07:20 |
BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY |
Bio-Techne |
|
Mon, 03/28/2022 - 06:09 |
European Medicines Agency Commences Review of Novel Gene Therapy Candidate Etranacogene Dezaparvovec for People with Hemophilia B |
CSL Behring |
|
Thu, 12/23/2021 - 04:48 |
France: Lysogene enters into a loan agreement of 15 million with the EIB |
European Invest... |
|
Wed, 12/15/2021 - 18:41 |
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases |
BioMarin |
|
Wed, 12/15/2021 - 17:13 |
Pfizer Invests $68.5 Million in New State-of-the-Art Facility in Durham, North Carolina to Further Advance Gene Therapy Capabilities |
Pfizer |
|
Tue, 12/14/2021 - 21:06 |
CSL Behring Receives Accelerated CHMP Assessment for Etranacogene Dezaparvovec for European Patients Living with Hemophilia B |
CSL Behring |
|
Sun, 12/12/2021 - 19:54 |
Experimental Gene Therapy Reverses Sickle Cell Disease for Years |
ColumbiaUniversity |
|
Thu, 12/02/2021 - 00:16 |
Cincinnati Childrens teams with CTI on joint venture |
Cincinnati Childrens |
|
Wed, 12/01/2021 - 05:20 |
- Dyno receives $18 million upfront and is eligible for milestone and royalty payments potentially exceeding $1.6 billion - |
Astellas |
|
Wed, 11/03/2021 - 18:10 |
Partners speed development of cystic fibrosis therapy |
Roslin Institute |
|
Mon, 10/18/2021 - 20:39 |
Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021 |
Cellectis |
|
Wed, 10/13/2021 - 15:03 |
CTI Announces Contract Development and Manufacturing Initiative During Alliance for Regenerative Medicine Meeting on the Mesa |
CTI Clinical Tr... |
|
Wed, 10/06/2021 - 20:38 |
Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing |
Terumo BCT |
|
Tue, 09/21/2021 - 05:05 |
Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss |
Novartis |
